We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EA:NASDAQElectronic Arts Inc. Analysis

Data as of 2026-05-19 - not real-time

$201.70

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Electronic Arts posted a robust Q1 CY2026 with revenue up 17.8% YoY to $2.12 billion and GAAP EPS beating estimates by 39.6%, underscoring the strength of its live‑service and full‑game franchises. Operating margin sits at 24% and free cash flow exceeds $2.2 billion, providing ample runway for reinvestment and dividend support. However, the stock trades at a forward P/E of ~20.7 versus an industry average of 17, and the DCF‑derived fair value of $193.6 is below the current price of $201.7, suggesting the market is pricing in premium growth expectations. Technical indicators are mixed: the 20‑day and 50‑day SMAs are nearly flat, RSI hovers around 52, and MACD shows a marginal bearish divergence, while volume is trending upward. Overall, the company’s fundamentals are solid, but valuation appears stretched in the near term.
The sector’s low beta (≈0.21) and modest 30‑day volatility (~3.8%) point to a relatively defensive profile, though gaming cycles can introduce medium‑level sector risk. Dividend sustainability looks strong with a 21.6% payout ratio and a modest 0.38% yield. Given the blend of strong cash generation, growth in live‑service bookings, and an overvalued price, the outlook favors a cautious stance: hold in the short‑to‑medium horizon while monitoring valuation compression, and consider a longer‑term position if price aligns with intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat with strong revenue growth
  • Technical indicators near neutral with slight bearish MACD
  • Current price above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained high operating and profit margins
  • Robust free cash flow supporting dividend and reinvestment
  • Valuation premium relative to industry peers

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Growth trajectory in live‑service and subscription models
  • Strong balance sheet with low debt‑to‑equity and ample cash
  • Potential for valuation convergence toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth11.90%
Profit Margin11.78%
P/E Ratio57.3
ROE13.49%
ROA5.70%
Debt/Equity27.41
P/B Ratio7.5
Op. Cash Flow$2.6B
Free Cash Flow$2.2B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI51.7
Support$199.45
Resistance$203.81
MA 20$201.51
MA 50$201.86
MA 200$195.95
MACDBearish
VolumeIncreasing
Fear & Greed Index89.05

Valuation

Fair Value$193.63
Target Price$202.80
Upside/Downside0.55%
GradeOvervalued
TypeGrowth
Dividend Yield0.38%

Risk Assessment

Beta0.21
Volatility3.84%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.